Shallot for COVID-19

c19early.org

COVID-19 Treatment Clinical Evidence

COVID-19 involves the interplay of 400+ viral and host proteins and factors, providing many therapeutic targets. c19early analyzes 6,000+ studies for 210+ treatments—over 17 million hours of research. Only three high-profit early treatments are approved in the US. In reality, many treatments reduce risk, with 25 low-cost treatments approved across 163 countries.

Naso/oropharyngeal treatment Effective Treatment directly to the primary source of initial infection.
Healthy lifestyles Protective Exercise, sunlight, a healthy diet, and good sleep all reduce risk.
Immune support Effective Vitamins A, C, D, and zinc show reduced risk, as with other viruses.
Thermotherapy Effective Methods for increasing internal body temperature, enhancing immune system function.
Systemic agents Effective Many systemic agents reduce risk, and may be required when infection progresses.
High-profit systemic agents Conditional Effective, but with greater access and cost barriers.
Monoclonal antibodies Limited Utility Effective but rarely used—high cost, variant dependence, IV/SC admin.
Acetaminophen Harmful Increased risk of severe outcomes and mortality.
Remdesivir Harmful Increased mortality with longer followup. Increased kidney and liver injury, cardiac disorders.

Shallot may be beneficial for COVID-19 according to the study below. COVID-19 involves the interplay of 400+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 11,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed shallot in detail.

Study suggesting benefit with shallot

Novriadhy et al., Shallot (Allium cepa L.) Planted In The Ts-of-RAMSAR-Classification Ecosystem Is Still Beneficial In The COVID-19 Treatment, IOP Conference Series: Earth and Environmental Science, doi:10.1088/1755-1315/995/1/012024

Abstract Rich in quercetin, shallot (Allium cepa L.) use is beneficial in controlling the COVID-19 pandemic since effective vaccines and pharmacotherapy are still in development. The study aimed to characterize functional groups of shallot tubers planted in the inorganic soil of the seasonal freshwater-wetland (IS-SFW)/Ts-of-RAMSAR-classification ecosystem. The shallot tubers that grew in IS-SFW for 60 days were manually harvested, sun-dried for seven days, and stored for two months before been pressed to produce sample juices. The peaks of wavenumber resulted from FTIR analysis were compared to the infrared database to determine possibly functional groups. The findings showed spectra changed in the fingerprint but not in the mid-IR other regions, indicated the IS-SFW did not affect functional groups beneficial in the COVID-19 treatment. The study concluded that shallot planted in IS-SFW is still beneficial in the COVID-19 treatment.